Pangea Bio

Curated by Signal

AI-powered drug discovery platform for neurological diseases

Overview

AI-powered drug discovery platform for neurological diseases. The company combines advanced central nervous system drug development with AI to drive pipeline of drugs. The company's products include OT-003 is a proprietary small molecule to treat a wide range of neurological disorders.

Key facts

Founded: 2021
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Remote Medical Support
App for teleconsultation
Health TechnologyLondon, United Kingdom
Treatment Abroad
Online medical tourism platform
Health TechnologyLondon, United Kingdom
Strove
Provider of fitness and wellbeing platform for employees
Health TechnologyLondon, United Kingdom

About Pangea Bio

What does Pangea Bio do?

AI-powered drug discovery platform for neurological diseases.

Where is Pangea Bio headquartered?

Pangea Bio is headquartered in London, United Kingdom.

When was Pangea Bio founded?

Pangea Bio was founded in 2021.

Which sector is Pangea Bio in?

Pangea Bio operates in Health Technology.

Who are Pangea Bio's competitors?

Companies similar to Pangea Bio include Remote Medical Support, Treatment Abroad, and Strove.